+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

DTP Vaccines Global Market Report 2021: COVID-19 Growth and Change to 2030

  • ID: 5446043
  • Report
  • September 2021
  • Region: Global
  • 175 pages
  • The Business Research Company

FEATURED COMPANIES

  • AJ Vaccines
  • AstraZeneca
  • Emergent BioSolutions Inc
  • Johnson & Johnson
  • Meiji Holdings Co. Ltd.
  • Novartis AG
  • MORE
DTP Vaccines Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global dtp vaccines market.



This report focuses on the dtp vaccines market which is experiencing strong growth. The report gives a guide to the dtp vaccines market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for dtp vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The DTP Vaccines market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider dtp vaccines market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The dtp vaccines market section of the report gives context. It compares the dtp vaccines market with other segments of the dtp vaccines market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, dtp vaccines indicators comparison.

Scope


Markets Covered:

  • By Product Type: DTaP; TD; Tdap
  • By Disease: Diphtheria; Pertussis; Tetanus
  • By End User: Hospitals; Clinics; Vaccination Centers

Companies Mentioned:


Merck & Co; Sanofi; GSK; Lanzhou Institute of Biological Products; Novartis AG

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data:


Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AJ Vaccines
  • AstraZeneca
  • Emergent BioSolutions Inc
  • Johnson & Johnson
  • Meiji Holdings Co. Ltd.
  • Novartis AG
  • MORE
1. Executive Summary

2. DTP Vaccines Market Characteristics

3. DTP Vaccines Market Trends and Strategies

4. Impact Of COVID-19 On DTP Vaccines

5. DTP Vaccines Market Size and Growth
5.1. Global DTP Vaccines Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global DTP Vaccines Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market

6. DTP Vaccines Market Segmentation
6.1. Global DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • DTaP
  • TD
  • Tdap
6.2. Global DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Diphtheria
  • Pertussis
  • Tetanus.
6.3. Global DTP Vaccines Market, Segmentation by End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Vaccination Centers
7. DTP Vaccines Market Regional and Country Analysis
7.1. Global DTP Vaccines Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global DTP Vaccines Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific DTP Vaccines Market
8.1. Asia-Pacific DTP Vaccines Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China DTP Vaccines Market
9.1. China DTP Vaccines Market Overview
9.2. China DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India DTP Vaccines Market
10.1. India DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan DTP Vaccines Market
11.1. Japan DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia DTP Vaccines Market
12.1. Australia DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia DTP Vaccines Market
13.1. Indonesia DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea DTP Vaccines Market
14.1. South Korea DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe DTP Vaccines Market
15.1. Western Europe DTP Vaccines Market Overview
15.2. Western Europe DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK DTP Vaccines Market
16.1. UK DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany DTP Vaccines Market
17.1. Germany DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France DTP Vaccines Market
18.4. France DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe DTP Vaccines Market
19.1. Eastern Europe DTP Vaccines Market Overview
19.2. Eastern Europe DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia DTP Vaccines Market
20.1. Russia DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America DTP Vaccines Market
21.1. North America DTP Vaccines Market Overview
21.2. North America DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA DTP Vaccines Market
22.1. USA DTP Vaccines Market Overview
22.2. USA DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America DTP Vaccines Market
23.1. South America DTP Vaccines Market Overview
23.2. South America DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil DTP Vaccines Market
24.1. Brazil DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East DTP Vaccines Market
25.1. Middle East DTP Vaccines Market Overview
25.2. Middle East DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa DTP Vaccines Market
26.1. Africa DTP Vaccines Market Overview
26.2. Africa DTP Vaccines Market, Segmentation by Product Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa DTP Vaccines Market, Segmentation by Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. DTP Vaccines Market Competitive Landscape and Company Profiles
27.1. DTP Vaccines Market Competitive Landscape
27.2. DTP Vaccines Market Company Profiles
27.2.1. Merck & Co
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Sanofi
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. GSK
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Lanzhou Institute of Biological Products
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Novartis AG
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. DTP Vaccines Pipeline Analysis

29. Key Mergers and Acquisitions in the DTP Vaccines Market

30. DTP Vaccines Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AJ Vaccines
  • AstraZeneca
  • Emergent BioSolutions Inc
  • Johnson & Johnson
  • Meiji Holdings Co. Ltd.
  • Novartis AG
  • MORE
Major players in the DTP vaccines market are Merck & Co, Sanofi, GSK, Lanzhou Institute of Biological Products, Novartis AG, Pfizer Inc, Johnson & Johnson, Seqirus, AJ Vaccines, and Bionet-Asia.

The global DTP vaccines market is expected to grow from $3.95 billion in 2020 to $4.22 billion in 2021 at a compound annual growth rate (CAGR) of 6.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $5.3 billion in 2025 at a CAGR of 6%.

The DTP vaccines market consists of sales of vaccines used for the treatment of diphtheria, tetanus, and pertussis (whooping cough) and related services by entities (organizations, sole traders and partnerships) that produce vaccines for diphtheria, tetanus, and pertussis (whooping cough). The different types of vaccines available for these diseases include DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, DT (diphtheria and tetanus) vaccine, Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine and Td (tetanus and diphtheria) vaccine. The market consists of revenue generated by the companies manufacturing DTP vaccines by the sales of these products.

The DTP vaccines market covered in this report is segmented by product type into DTaP, TD, Tdap. It is also segmented by disease into diphtheria, pertussis, tetanus and by end-user into hospitals, clinics, vaccination centers.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The inadequate access to vaccines in under-developed countries is expected to limit the growth of the DTP vaccines global market. According to the World Health Organization’s global estimates, around 19.4 million infants did not had access to DTP vaccines and around 60% of these children live in under-developed and developing countries. Countries such as the Central African Republic, Chad, Equatorial Guinea, Guinea, Samoa, Somalia, South Sudan, Syrian Arab Republic, and Ukraine have less than 50% coverage of DTP vaccination. Lack of access to vaccines in under-developed countries is expected to hamper the market growth.

In May 2020, Merck acquired Thermis, a company focused on vaccines and immuno-modulation therapies for infectious diseases, for an undisclosed amount. Thermis is involved in the discovery, development and production of vaccines with a sophisticated and versatile technology platform. Merck is expected to leverage the vaccine technology enhanced by Thermis and the company will become a fully-owned subsidiary of Merck after completion of this deal.

Governments across the world are encouraging the R&D of DTP vaccines to disallow the spread of the diseases. Countries such as India have the Universal Immunisation Programme that aims to provide recommended vaccines against tuberculosis, polio and other diseases including diphtheria, tetanus and whooping cough for all Indian children. The country regularly conducts vaccination drives, which is expected to positively impact the growth of the market. These initiatives are expected to drive the growth of the market in the forecast period.

Companies in the DTP vaccines market are increasingly investing in manufacturing DTP combination vaccines, which reduces multiple vaccination shots for immunization against infectious disease. DTP combination vaccines such as tetravalent (DTP-HepB), pentavalent (DTP-HepB-Hib) and hexavalent vaccine (DTP-Hib-HepB-IPV) are available to provide the same protection as individual vaccine shots given separately.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Merck & Co
  • Sanofi
  • GSK
  • Lanzhou Institute of Biological Products
  • Novartis AG
  • Pfizer Inc
  • Johnson & Johnson
  • Seqirus
  • AJ Vaccines
  • Bionet-Asia
  • Massbiologics
  • Meiji Holdings Co. Ltd.
  • Panacea Biotec Ltd
  • Serum Institute of India Pvt. Ltd.
  • Wyeth
  • Chiron Pharmaceutical Pvt Ltd
  • Protein Sciences Corporation
  • Astellas Pharma US Inc
  • AstraZeneca
  • Emergent BioSolutions Inc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll